• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 207/06 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms

Patent holdings for IPC class C07D 207/06

Total number of patents in this class: 529

10-year publication summary

43
41
36
52
37
37
29
20
33
20
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
The Regents of the University of California
20924
10
Alkermes Pharma Ireland Limited
255
9
University of Pittsburgh - Of the Commonwealth System of Higher Education
3357
9
Nocion Therapeutics, Inc.
52
9
Tetraphase Pharmaceuticals, Inc.
52
8
Sanofi
4332
8
F. Hoffmann-La Roche AG
7792
7
BASF SE
21318
7
Sunovion Pharmaceuticals Inc.
244
6
Novartis AG
10172
5
Bristol-myers Squibb Company
4761
5
Boehringer Ingelheim International GmbH
4480
5
Cytokinetics, Inc.
251
5
The United States Government AS represented by The Department of Veterans Affairs
1356
5
Guangdong Raynovent Biotech Co., Ltd.
55
5
Lunella Biotech, Inc.
102
5
Conopco, Inc.
5129
4
LG Chem, Ltd.
17978
4
ExxonMobil Chemical Patents Inc.
3759
4
Takeda Pharmaceutical Company Limited
2700
4
Other owners 405